Definitive Contract W81XWH18C0193
Award Date
9/24/18
Potential Completion Date
9/23/22
Potential Value
$1.1M
Federal Agency
Medical Command
Awardee
Banyan Biomarkers, Inc.
Ultimate Awardee
Banyan Biomarkers, Inc.
NAICS Category
339112 - Surgical and Medical Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fort Detrick, MD 21702, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as W81XWH16P0120, was issued by the Medical Command (MEDCOM) component of the U.S. Department of Defense to Banyan Biomarkers, Inc., a for-profit organization. The contract, with a ceiling value of $192,900.00, is for the evaluation of samples related to GFAP (Protein #1796). The contract is a firm fixed-price purchase order with a completion date of March 24, 2017. The place of performance is San Diego, CA. This contract award was not set aside for any...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Neurotheranostics Inc., a minority-owned small disadvantaged business. The contract, valued at $146,079.20, is for research to develop a point-of-injury therapy to maintain and stabilize moderate-to-severe traumatic brain injury (TBI). The contract is a firm-fixed-price definitive contract, with the work to be performed in Walled Lake, Michigan. This SBIR Phase I contract...
The U.S. Defense Health Agency awarded a $749,437 fixed-price level-of-effort contract to Gryphon Bio Inc., a small disadvantaged business, to conduct a feasibility study on a single platform blood test for traumatic brain injury (TBI) biomarkers. This new research and development contract is part of the Congressionally Directed Medical Research Program and has a period of performance through December 2025. Gryphon Bio specializes in diagnostic and therapeutic solutions for brain health...
This is a $2,093,995.00 fixed-price level of effort Definitive Contract awarded by the Defense Health Agency to Medicortex Finland OYJ, a for-profit limited liability company based in Finland. The contract is for the purpose of "Rapid Detection of Mild Traumatic Brain Injury in a Noninvasive Body Fluid Sample" for the United States Army Medical Research and Development Command. The contract has an ultimate completion date of March 31, 2025 and was awarded on September 19, 2022. The...
This is a $1,878,955.92 fixed-price level of effort contract awarded by the Air Mobility Command, a component of the U.S. Department of Defense, to Beyond Barriers Therapeutics, Inc. in Glencoe, Illinois. The contract is for the development of an intranasal treatment for mild traumatic brain injury, awarded under a Broad Agency Announcement issued by the Army Medical Command. The original solicitation did not utilize a set-aside designation. This award is not associated with a larger contract...
The U.S. Army Medical Research Acquisition Activity (USAMRAA) awarded a $2,743,260.95 cost-plus-fixed-fee definitive contract to Q30 Sports Science, LLC (doing business as Q30 Innovations) to develop a small wearable traumatic brain injury (TBI) prevention device. The contract has a period of performance through March 2, 2026 and was not set aside for any specific business category. The contract stems from a sole-source procurement notice seeking two Applied Biosystems 3500XL Genetic Analyzer...
<p>The Department of the Army Medical Command awarded a $3,330,712.44 Firm Fixed Price contract to Infrascan Inc., a for-profit manufacturer, for the development and support of a POI-TBI (Portable Optical Imaging for Traumatic Brain Injury) device. The contract was awarded on September 27, 2017 and has a completion date of September 26, 2019. This contract is not associated with a larger vehicle and does not have a set-aside designation.</p>
This $15,491,795.28 prime contract was awarded by the Defense Health Agency to the University of Birmingham, a private university and non-profit organization, to conduct a prospective cohort biomarker study on mild traumatic brain injury (MTBI) titled "MTBI-PREDICT". The contract was awarded under a Broad Agency Announcement issued by the U.S. Army Medical Research and Development Command (USAMRDC) to support its mission of providing medical solutions for American service members and...
The Department of the Army Medical Command awarded a firm-fixed-price purchase order to Wetware Biosystems LLC, a self-certified small disadvantaged business, for the SBIR Program Phase I solicitation titled "IRONCROWN: A Novel Medical Device for the Prehospital Diagnosis and Treatment of Traumatic Brain Injury". The award, totaling $249,975.56, has a completion date of March 15, 2022 and is set aside for small businesses. The award supports research and development of a medical device...
This is a firm-fixed price contract awarded by the U.S. Army Medical Research Acquisition Activity (USAMRAA) to Abbott Laboratories Inc., a subsidiary of the larger Abbott Laboratories corporation. The contract, valued at $13,548,494.28, is for the development of an Food and Drug Administration (FDA) approved assay cartridge for the i-STAT point-of-care device. The cartridge is intended to screen for the presence of two protein biomarkers, Ubiquitin Carboxy-Terminal Hydrolase-L1 (UCH-L1) and...